Numerous studies have shown that non-coding RNAs play crucial roles in the development
and progression of various tumor cells. Plasmacytoma variant translocation 1 (PVT1) mainly …

Abstract p53 is the major mediator of the tumor suppressor response. It participates in
apoptosis and senescence and can respond to DNA damage. As a crucial sequence …

While estrogen receptor β (ERβ) may impact the progression of non-small cell lung cancer
(NSCLC), its linkage to alteration of the vasculogenic mimicry (VM) formation to influence the …

Long noncoding RNAs (lncRNAs) are implicated in human cancer, but their mechanisms of
action are largely unknown. In this study, we investigated lncRNA alterations that contribute …

Background. Cervical cancer is one of the most frequent malignancies among females
worldwide. Increasing evidence have indicated the participation of long noncoding RNAs …

Accumulating evidence revealed that dysregulated long noncoding RNAs (lncRNAs) were
involved in tumorigenesis and progression. This study is supposed to reveal the effects of …

The dysregulation and mutation of long non-coding RNAs (lncRNAs) have been proved to
result in a variety of human diseases. Identifying potential disease-related lncRNAs may …

In this study, we report that lncRNA SNHG16 is upregulated in non-small cell lung cancer
(NSCLC) tissues, and correlates with tumor size, TNM stage and lymph node metastasis …

Lung cancer is the most common malignancy with the highest mortality worldwide. Emerging
research has demonstrated that long non‑coding RNAs (lncRNAs), a key genomic product …

Lung cancer is the most common cancer all around the world, with high morbidity and
mortality. Long noncoding RNA (lncRNA) has been reported to have a critical role in non …